My Quote Request
6505-00-138-7344
20 Products
RENOCAT-76
DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM INJECTION,USP
NSN, MFG P/N
6505001387344
NSN
6505-00-138-7344
RENOCAT-76
DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM INJECTION,USP
NSN, MFG P/N
6505001387344
NSN
6505-00-138-7344
MFG
BRACCO DIAGNOSTICS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 PERCENTAGE, W/V DIATRIZOATE SODIUM ACTIVE INGREDIENT AND 66.000 PERCENTAGE, W/V MEGLUMINE DIATRIZOATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DIATRIZOATE MEGLUMINE-DIATRIZOATE SODIUM INJ 200 ML BT 10 BX
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
III SUPPLEMENTARY FEATURES: CONTAINS 4.48 MG SODIUM
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 200.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00270-0860-50
DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM INJECTION,USP
NSN, MFG P/N
6505001387344
NSN
6505-00-138-7344
NDC00270-0860-50
DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM INJECTION,USP
NSN, MFG P/N
6505001387344
NSN
6505-00-138-7344
MFG
BRACCO DIAGNOSTICS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 PERCENTAGE, W/V DIATRIZOATE SODIUM ACTIVE INGREDIENT AND 66.000 PERCENTAGE, W/V MEGLUMINE DIATRIZOATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DIATRIZOATE MEGLUMINE-DIATRIZOATE SODIUM INJ 200 ML BT 10 BX
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
III SUPPLEMENTARY FEATURES: CONTAINS 4.48 MG SODIUM
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 200.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00407-0778-02
DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM INJECTION,USP
NSN, MFG P/N
6505001387344
NSN
6505-00-138-7344
NDC00407-0778-02
DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM INJECTION,USP
NSN, MFG P/N
6505001387344
NSN
6505-00-138-7344
MFG
STERLING-WINTHROP RESEARCH INSTITUTE A DIV OF STERLING DRUG INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 PERCENTAGE, W/V DIATRIZOATE SODIUM ACTIVE INGREDIENT AND 66.000 PERCENTAGE, W/V MEGLUMINE DIATRIZOATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DIATRIZOATE MEGLUMINE-DIATRIZOATE SODIUM INJ 200 ML BT 10 BX
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
III SUPPLEMENTARY FEATURES: CONTAINS 4.48 MG SODIUM
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 200.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00024-1212-02
BUPIVACAINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505001387345
NSN
6505-00-138-7345
NDC00024-1212-02
BUPIVACAINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505001387345
NSN
6505-00-138-7345
MFG
SANOFI-SYNTHELABO INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.250 PERCENTAGE,W/V BUPIVACAINE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: NERVE BLOCK
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BUPIVACAINE HYDROCHLORIDE INJECTION USP 50 ML AMPUL 5 AMPULS BX
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
III SUPPLEMENTARY FEATURES: SINGLE-DOSE AMPUL
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL
SPECIAL FEATURES: FOR CAUDAL,EPIDURAL OR PERIPHERAL NERVE BLOCK
TOTAL PRIMARY CONTAINER QUANTITY: 5
Related Searches:
NDC00074-1559-50
BUPIVACAINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505001387345
NSN
6505-00-138-7345
NDC00074-1559-50
BUPIVACAINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505001387345
NSN
6505-00-138-7345
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.250 PERCENTAGE,W/V BUPIVACAINE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: NERVE BLOCK
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BUPIVACAINE HYDROCHLORIDE INJECTION USP 50 ML AMPUL 5 AMPULS BX
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
III SUPPLEMENTARY FEATURES: SINGLE-DOSE AMPUL
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL
SPECIAL FEATURES: FOR CAUDAL,EPIDURAL OR PERIPHERAL NERVE BLOCK
TOTAL PRIMARY CONTAINER QUANTITY: 5
Related Searches:
NDC00409-1610-50
BUPIVACAINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505001387347
NSN
6505-00-138-7347
NDC00409-1610-50
BUPIVACAINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505001387347
NSN
6505-00-138-7347
MFG
AMERISOURCEBERGEN DRUG CORPORATION DIV CORPORATE OFFICE
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 PERCENTAGE,W/V BUPIVACAINE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: NERVE BLOCK
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BUPIVACAINE HYDROCHLORIDE INJECTION USP 50 ML VIAL
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
III SUPPLEMENTARY FEATURES: MULTIPLE-DOSE VIAL
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL,MULTIPLE DOSE
Related Searches:
NDC00182-0144-01
QUINIDINE SULFATE TABLETS,USP
NSN, MFG P/N
6505001387400
NSN
6505-00-138-7400
NDC00182-0144-01
QUINIDINE SULFATE TABLETS,USP
NSN, MFG P/N
6505001387400
NSN
6505-00-138-7400
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS QUINIDINE SULFATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: QUINIDINE SULFATE TABLETS USP 200 MG 100 TABLETS PER BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
Related Searches:
NDC00185-4343-01
QUINIDINE SULFATE TABLETS,USP
NSN, MFG P/N
6505001387400
NSN
6505-00-138-7400
NDC00185-4343-01
QUINIDINE SULFATE TABLETS,USP
NSN, MFG P/N
6505001387400
NSN
6505-00-138-7400
MFG
EON LABS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS QUINIDINE SULFATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: QUINIDINE SULFATE TABLETS USP 200 MG 100 TABLETS PER BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
Related Searches:
NDC00364-0229-01
QUINIDINE SULFATE TABLETS,USP
NSN, MFG P/N
6505001387400
NSN
6505-00-138-7400
NDC00364-0229-01
QUINIDINE SULFATE TABLETS,USP
NSN, MFG P/N
6505001387400
NSN
6505-00-138-7400
MFG
CARDINAL HEALTH 100 INC DBA BINDLEY WESTERN TENNESSEE DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS QUINIDINE SULFATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: QUINIDINE SULFATE TABLETS USP 200 MG 100 TABLETS PER BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
Related Searches:
NDC00536-4432-01
QUINIDINE SULFATE TABLETS,USP
NSN, MFG P/N
6505001387400
NSN
6505-00-138-7400
NDC00536-4432-01
QUINIDINE SULFATE TABLETS,USP
NSN, MFG P/N
6505001387400
NSN
6505-00-138-7400
MFG
RUGBY GROUP INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS QUINIDINE SULFATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: QUINIDINE SULFATE TABLETS USP 200 MG 100 TABLETS PER BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
Related Searches:
NDC00591-5438-01
QUINIDINE SULFATE TABLETS,USP
NSN, MFG P/N
6505001387400
NSN
6505-00-138-7400
NDC00591-5438-01
QUINIDINE SULFATE TABLETS,USP
NSN, MFG P/N
6505001387400
NSN
6505-00-138-7400
MFG
CARDINAL HEALTH 200 LLC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS QUINIDINE SULFATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: QUINIDINE SULFATE TABLETS USP 200 MG 100 TABLETS PER BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
Related Searches:
NDC00904-2201-60
QUINIDINE SULFATE TABLETS,USP
NSN, MFG P/N
6505001387400
NSN
6505-00-138-7400
NDC00904-2201-60
QUINIDINE SULFATE TABLETS,USP
NSN, MFG P/N
6505001387400
NSN
6505-00-138-7400
MFG
MAJOR PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS QUINIDINE SULFATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: QUINIDINE SULFATE TABLETS USP 200 MG 100 TABLETS PER BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
Related Searches:
NDC00597-0020-01
MESORIDAZINE BESYLATE TABLETS,USP
NSN, MFG P/N
6505001387980
NSN
6505-00-138-7980
NDC00597-0020-01
MESORIDAZINE BESYLATE TABLETS,USP
NSN, MFG P/N
6505001387980
NSN
6505-00-138-7980
MFG
BOEHRINGER INGELHEIM PHARMACEUTICALS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS MESORIDAZINE ACTIVE INGREDIENT
COATING FEATURE: SUGAR
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,BOEHRINGER INGLEHEIM
Related Searches:
SERENTIL
MESORIDAZINE BESYLATE TABLETS,USP
NSN, MFG P/N
6505001387980
NSN
6505-00-138-7980
SERENTIL
MESORIDAZINE BESYLATE TABLETS,USP
NSN, MFG P/N
6505001387980
NSN
6505-00-138-7980
MFG
BOEHRINGER INGELHEIM PHARMACEUTICALS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS MESORIDAZINE ACTIVE INGREDIENT
COATING FEATURE: SUGAR
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,BOEHRINGER INGLEHEIM
Related Searches:
SERENTIL TABLETS
MESORIDAZINE BESYLATE TABLETS,USP
NSN, MFG P/N
6505001387980
NSN
6505-00-138-7980
SERENTIL TABLETS
MESORIDAZINE BESYLATE TABLETS,USP
NSN, MFG P/N
6505001387980
NSN
6505-00-138-7980
MFG
BOEHRINGER INGELHEIM PHARMACEUTICALS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS MESORIDAZINE ACTIVE INGREDIENT
COATING FEATURE: SUGAR
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,BOEHRINGER INGLEHEIM
Related Searches:
NDC65162-0517-10
PHENAZOPYRIDINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505001388461
NSN
6505-00-138-8461
NDC65162-0517-10
PHENAZOPYRIDINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505001388461
NSN
6505-00-138-8461
MFG
AMNEAL PHARMACEUTICALS LLC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS PHENAZOPYRIDINE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PHENAZOPYRIDINE HYDROCHLORIDE TABLETS USP 100 MG 100 TABLETS BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
Related Searches:
NDC00089-0221-10
ORPHENADRINE CITRATE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505001388462
NSN
6505-00-138-8462
NDC00089-0221-10
ORPHENADRINE CITRATE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505001388462
NSN
6505-00-138-8462
MFG
3M COMPANY HEALTH CARE/MFG
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS ORPHENADRINE CITRATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ORPHENADRINE CITRATE EXTENDED-RELEASE TABLETS 100 MG 100 TABS BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NORFLEX
ORPHENADRINE CITRATE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505001388462
NSN
6505-00-138-8462
NORFLEX
ORPHENADRINE CITRATE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505001388462
NSN
6505-00-138-8462
MFG
3M COMPANY HEALTH CARE/MFG
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS ORPHENADRINE CITRATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ORPHENADRINE CITRATE EXTENDED-RELEASE TABLETS 100 MG 100 TABS BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NORFLEX TABLETS
ORPHENADRINE CITRATE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505001388462
NSN
6505-00-138-8462
NORFLEX TABLETS
ORPHENADRINE CITRATE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505001388462
NSN
6505-00-138-8462
MFG
3M COMPANY HEALTH CARE/MFG
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS ORPHENADRINE CITRATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ORPHENADRINE CITRATE EXTENDED-RELEASE TABLETS 100 MG 100 TABS BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
0018507
FLUOROMETHOLONE OPHTHALMIC SUSPENSION,USP
NSN, MFG P/N
6505001389875
NSN
6505-00-138-9875
0018507
FLUOROMETHOLONE OPHTHALMIC SUSPENSION,USP
NSN, MFG P/N
6505001389875
NSN
6505-00-138-9875
MFG
ASSOCIATION PHARMACEUTIQUE BELGE
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.100 PERCENTAGE, W/V FLUOROMETHOLONE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FLUOROMETHOLONE OPHTHALMIC SUSPENSION USP 0.1% 5 ML BT
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH OPHTHALMIC TIP